THE FEATURES OF REALIZATION OF REPLACMENT HORMONAL THERAPY IN WOMEN WITH METABOLIC SYNDROME AND DISHORMONAL DISORDERS OF MAMMARY GLAND

The usage of Femoston is optimal for realization of substitutive replacment therapy in patients with metabolic syndrome and diffuse dishormonal disorders of mammary gland was founded. The Femoston application has decreased clinical symptoms of climacteric disorders and allowed to control metabolic and cardiovascular pathology. The usage of Femoston gives to correct effects of hypoestrogenemia and comparative hyperandrogenemia on the mammary gland, prophylaxis of cancer. The high effectiveness of Femoston to combine with absence of incidental reactions.